The disruption of mitochondrial function is a key component of apoptosis in most cell types. Localization of Bcl-2 to the outer mitochondrial and endoplasmic reticulum membranes is consistent with a role in the inhibition of many forms of apoptosis. In Rat-1 cells, a Bcl-2 mutant targeted exclusively to the endoplasmic reticulum (Bcl-cb5) was eective at inhibiting apoptosis induced by serum starvation/myc, or ceramide but not apoptosis induced by etoposide. The former conditions cause a decrease in mitochondrial transmembrane potential (Dc m ) as an early event that precedes the release of cytochrome c from mitochondria. By contrast, when cells are exposed to etoposide, a situation in which cytochrome c release and membrane localization of the pro-apoptotic protein Bax precede loss of Dc m , wild type Bcl-2 but not Bcl-cb5 prevents apoptosis. Therefore, Bcl-2 functions in spatially distinct pathways of apoptosis distinguished by the order of cytochrome c release and loss of Dc m . Oncogene (2001Oncogene ( ) 20, 1939Oncogene ( ± 1952 
Introduction
A large body of data supports the proposal that events localized at the mitochondria serve as sensors, regulators and ampli®ers of apoptosis (reviewed in Green and Kroemer, 1998) . Bcl-2 localization to the outer mitochondrial membrane is consistent with its role in regulating many forms of apoptosis upstream of the caspase eector sequence (Kroemer, 1997) . However, Bcl-2 is also found at other intracellular membrane sites such as the endoplasmic reticulum (ER) and nuclear membrane (Zhu et al., 1996) . To directly address the physiological relevance of the speci®c intracellular localization of Bcl-2, we created a mutant form of Bcl-2 in which the endogenous insertion sequence, responsible for membrane targeting and integration, was replaced by one from the ER speci®c isoform of cytochrome b5 (Zhu et al., 1996) . This mutant, designated Bcl-cb5, is targeted exclusively to the ER, and is capable of inhibiting apoptosis induced by either serum starvation and myc overexpression in Rat-1 ®broblasts, or exposure to brefeldin A or tunicamycin in rat embryo ®broblasts, but incapable of preventing serum starvation induced apoptosis in the Madin Darby canine kidney epithelial cell line (Zhu et al., 1996; Haecki et al., 2000) .
What determines whether Bcl-cb5 is eective? The dierence may be due to a cell speci®c eect (epithelial cells versus ®broblasts), where some cell types activate an apoptotic pathway that can be inhibited at the ER. This distinction is analogous to the recent proposal by Krammer's group, where two types of cells were identi®ed that dier in their dependence on the apoptogenic activity of mitochondria. The presence of mitochondrial dysfunction then determines whether Bcl-2/Bcl-XL can inhibit Fas mediated apoptosis in that cell type (Scadi et al., 1998) . This model predicts that if any form of apoptosis in Rat-1 ®broblasts is blocked by Bcl-cb5 then all forms of apoptosis would be inhibited by Bcl-cb5. However, we have recently reported that Bcl-2, but not Bcl-cb5, can prevent etoposide induced apoptosis in Rat-1 cells (Lee et al., 1999) . Thus, both ER-dependent and ER-independent apoptosis pathways are present within the same cell.
Are Bcl-cb5 and Bcl-2 regulating apoptosis via a similar mechanism? In many dierent cell types, the sequential reduction of the Dc m and generation of reactive oxygen species are early changes in mitochondrial function that may or may not directly mediate the later manifestations of apoptosis, including alterations in the plasma membrane and fragmentation of DNA (Zamzami et al., 1995 Marchetti et al., 1996; Susin et al., 1996) . Many metabolic alterations can aect mitochondrial membrane potential. However, pharmacologic inhibition of the disruption of Dc m prevents later manifestations of apoptosis in many experimental systems, suggesting that it may function as a critical coordinating step . The release to the cytoplasm of cytochrome c from the mitochondrial intermembrane space is another key event in activating the downstream eector phase of apoptosis (Zou et al., 1997) . The relative role played by cytochrome c release as compared to the loss of Dc m in activating the irreversible eector phase of apoptosis has yielded con¯icting results in dierent cell systems (Bossy-Wetzel et al., 1998; Petit et al., 1998; Finucane et al., 1999) . Our data provide a possible resolution of the controversy regarding the order of loss of Dc m and cytochrome c release. By determining whether apoptosis can be inhibited by Bclcb5 we have identi®ed two spatially distinct pathways for apoptosis present in Rat-1 cells. Apoptosis elicited by stimuli that lead to a decrease in Dc m , that precedes cytochrome c release is eectively inhibited by Bcl-cb5. By contrast, in the same cell type, Bcl-cb5 is not eective at inhibiting apoptosis induced by stimuli that cause mitochondrial translocation of Bax and redistribution of cytochrome c at a time when decreased Dc m is not yet apparent. Thus two pathways, distinguishable by the order of early changes at the mitochondria, can be activated in the same cell, but only one pathway is regulated by events at the ER.
Results

Bcl-cb5 prevents mitochondrial changes induced by serum starvation/myc
Serum starvation and constitutive c-myc overexpression induces apoptosis eciently in Rat-1 ®broblasts (Evan et al., 1992) . A mutant Bcl-2 targeted exclusively to the endoplasmic reticulum (Bcl-cb5) is as active as wild type Bcl-2 in preventing this form of cell death, as measured by changes in nuclear morphology and clonal survival (Zhu et al., 1996) . To determine whether Bcl-cb5 prevented apoptosis upstream or downstream of mitochondrial changes we measured the decrease in Dc m and generation of reactive oxygen species during apoptosis in Rat-1 cells. In vectortransfected control cells, inducing apoptosis by serum starvation and c-myc overexpression lead to decreased Dc m in 46% of cells as measured by DIOC 6 (3) uorescent intensity, and the generation of reactive oxygen species in 10% of cells after 18 h. In contrast, these values were 10 and 3% in untreated cells, respectively (Figure 1a, control) . Apoptosis induced by serum starvation/myc is also associated with other features such as the presence of phosphatidyl serine on the cell surface (PS, Figure 1b ) and fragmentation of nuclear DNA (Figure 1c ). Both of these features are characteristic of programmed cell death as a result of mitochondrial dysfunction (Zamzami et al., 1995; Marchetti et al., 1996) . As expected from previous observations Zhu et al., 1996) , expression of Bcl-2 prevented all of these manifestations of apoptosis (Figure 1a ± c) . Signi®cantly, Bcl-cb5 was as eective as Bcl-2 in preventing these features of apoptosis, both mitochondrial ( Figure 1a ) and postmitochondrial (Figure 1b,c) . Thus, Bcl-2 does not have to be localized to mitochondria to prevent the loss of Dc m associated with the early phase of apoptosis caused by serum starvation/myc.
Bcl-cb5 inhibits the mitochondrial changes associated with ceramide and staurosporine induced apoptosis
We previously reported that other agents including etoposide and tert-butyl hydroperoxide induce apoptosis that is not blocked by Bcl-cb5 Lee et al., 1999) . Therefore, the question arose as to whether apoptosis that is blocked by Bcl-cb5 resulted from activation of an unique pathway induced by serum starvation/myc but not other agents. As part of a screen of agents that induce apoptosis that can be blocked by Bcl-2, we discovered that Bcl-cb5 protects Rat-1 ®broblasts from apoptosis after a 6 h exposure to either ceramide or the kinase inhibitor staurosporine. Thus, Bcl-cb5 prevented loss of Dc m (Figure 2a) , externalization of phosphatidyl serine (PS, Figure 2b ), and fragmentation of DNA (Figure 2c ) during apoptosis induced by either of these agents. The identi®cation of multiple stimuli that induce a program of apoptosis that can be blocked by Bcl-cb5 argues that the pathway blocked by Bcl-cb5 may be a relevant response to many agents and in other cell types.
Caspases are critical and conserved components of the eector phase of apoptosis that directly degrade many cellular macromolecules, as well as activating other enzymes that degrade DNA (Thornberry and Lazebnik, 1998). As a consequence, inhibition of caspase activity prevents many, but not all, of the features of programmed cell death (Xiang et al., 1996 McCarthy et al., 1997 . The role of caspases in the earlier recognition and regulatory phases of apoptosis is more variable, and depends upon the cell type and speci®c stimulus for apoptosis (Green and Kroemer, 1998) . Moreover, the decrease in Dc m during apoptosis can occur by both caspase-dependent, and -independent pathways (Susin et al., 1997) . If the decrease in Dc m caused by serum starvation/myc, ceramide or staurosporine depends on prior activation of caspases this may explain why Bcl-2 localized to the endoplasmic reticulum can prevent this mitochondrial dysfunction. To investigate whether the stabilization of the mitochondrial transmembrane potential by Bcl-cb5 was due to a caspase dependent event we determined whether the decrease in Dc m caused by staurosporine or ceramide in Rat-1 cells could be prevented by the general caspase inhibitor zVAD-fmk. In both cases, addition of zVAD-fmk had no eect on the decrease in Dc m in vector-transfected cells ( Figure  2a) . However, addition of zVAD-fmk resulted in partial inhibition of externalization of phosphatidyl serine after exposure of vector-transfected cells to either staurosporine or ceramide (Figure 2b ). By contrast, zVAD-fmk completely prevented DNA fragmentation after exposure to either drug ( Figure  2c ), consistent with the caspase dependent activation of a DNAse during apoptosis Sakahira et al., 1998) . Thus, staurosporine and ceramide elicit a multistep apoptotic pathway, which includes components that are both caspase dependent and independent. However, the early step that results in the decrease in Dc m , that is inhibited by Bcl-cb5, is not dependent on caspase activation. Thus, Bcl-cb5 does not prevent the loss of Dc m by inhibiting cytoplasmic or endoplasmic reticulum associated caspases (Nakagawa et al., 2000) .
Decrease in Dc m precedes cytochrome c release in serum starvation/myc and ceramide induced apoptosis
The release of cytochrome c to the cytoplasm from the intermembrane space of mitochondria can activate the downstream eector phase of apoptosis by binding to apaf-1 and caspase 9 (Zou et al., 1997) . In some systems, cytochrome c release is believed to precede loss of Dc m (Kluck et al., 1997; Yang et al., 1997) . However, in other circumstances, decreased Dc m is the prior event (Petit et al., 1998) . To determine if the temporal order of cytochrome c release and decrease in Dc m is a distinguishing feature of the ability of Bcl-cb5 to block apoptosis, individual cells undergoing apoptosis were examined. We used laser scanning confocal microscopy to monitor changes to Dc m , using the potentiometric dye Mitotracker, and the localization of In vector-transfected cells growing in normal serum, the mitochondria retain cytochrome c and Dc m as evidenced by cytochrome c staining and the accumulation of Mitotracker dye, respectively (Figures 3 and 4) . When these cells were exposed to the protonophore m- Figure 2 Bcl-cb5 prevents induction of apoptosis by ceramide (Cer) or staurosporine (STS) in the presence or absence of zVADfmk. Rat-1 ®broblasts cultured with 50 mM ceramide or 100 nM staurosporine in the presence (solid bars) or absence (open bars) of 50 mM zVAD-fmk for 12 h followed by cyto¯uorometric analysis of (a) Dc m ; (b) phosphatidylserine exposure on the plasma membrane; (c) sub-diploidy. Experiments were repeated three times with similar results CICCP to induce a loss of mitochondrial membrane potential in all of the cells, the Mitotracker was no longer localized to mitochondria but was found throughout the cell. In contrast there is no change in Hsp-60 or cytochrome c staining ( Figure 3 and data not shown).
In vector-transfected cells exposed to serum starvation/myc for 24 h, there is no evidence of cytochrome c release from mitochondria (data not shown), however at this time point 26% of the cells showed decreased Dc m (Table 1 ). Both Bcl-2 and Bcl-cb5 prevented loss of Dc m with equal eciency in these cells as measured (Table 1) and cyto¯uorometry with DiOC 6 3 ( Figure 1a ). The fact that both dyes give qualitatively similar results even though in one case cells are detached from the growth support argues that these measurements accurately re¯ect membrane potential changes.
Similar to serum starvation/myc, exposure of vectortransfected cells to ceramide for 6 h resulted in a signi®cant proportion of cells demonstrating a loss of Dc m (Figures 2a and 4b , arrowheads). Assay of mitochondrial transmembrane potential at 1.5, 3 and 6 h revealed that the total proportion of cells with reduced Dc m after exposure to ceramide increased over time (data not shown). After incubation in ceramide for 6 h, 64% of the cells had reduced Dc m (Table 1) . By contrast, less than 20% of Bcl-2 or Bcl-cb5 expressing cells exhibited reduced Dc m after 6 h exposure to ceramide (Table 1 and Figure 4b , arrowheads). Similar to serum starvation/myc, when cells were treated with ceramide, cytochrome c release was not observed in either vector control or Bcl-cb5 cells, even in cells with reduced Dc m (Figure 4b ). Despite the lack of cytochrome c release, cleavage of the caspase substrate PARP is evident in vector control cells subjected to serum starvation/myc or ceramide at time points where we observe loss of Dc m ( Figure 5 ). Expression of Bcl-cb5 delayed PARP cleavage with both apoptotic stimuli.
If loss of Dc m is due to permeability transition then exposure to the permeability transition inhibitor cyclosporin A should be delay the loss Dc m by approximately 60 min (Zamzami et al., 1995) . When Rat-1 cells were treated with cyclosporin A and ceramide we were unable to detect a delay in loss of Dc m as measured by Mitotracker staining (data not shown). Therefore within the temporal resolution of our experimental system the loss of Dc m induced by ceramide in adherent cells appears to be mechanistically distinct from permeability transition.
In contrast to cells subjected to serum starvation/ myc or ceramide, treatment with etoposide for 6 h, resulted in diuse cytochrome c staining in 20% of the adherent cells, a result consistent with release of mitochondrial cytochrome c into the cytoplasm (Figures 3 and 4c , arrowheads). Even though cytochrome c staining was diuse (cytoplasmic), staining for Hsp60 remained mitochondrial (Figure 3 ). This result is consistent with loss of integrity of the outer but not inner mitochondrial membrane. However, it is evident from the micrographs that even in the cells with diuse staining, a proportion of the cytochrome c was still found to co-localize with mitochondria (Figures 3 and 4c) . PARP cleavage was evident in the cells by 6 h after adding etoposide, con®rming that apoptosis was well underway (data not shown). However, at this time point none of the cells had decreased Dc m , including those with diuse staining for cytochrome c (Figure 4c , arrowheads). Consistent with the inability of Bcl-cb5 to prevent etoposide induced apoptosis, the proportion of Bcl-cb5 expressing cells with diuse cytochrome c staining was the same as that for vector control (Figure 4c ).
Bcl-cb5 does not prevent etoposide mediated release of cytochrome c Selective release of cytochrome c is most often assayed by immunoblotting of cell fractions. It is possible that cytochrome c release would appear earlier when assayed by blotting than it does in micrographs of adherent cells, because both adherent and nonadherent cells are assayed. Furthermore, fragmentation of mitochondria during cell breakage and fractionation (perhaps symptomatic of the initial swelling of mitochondria reported to precede rupture of the outer membrane (Petit et al., 1998; Vander Heiden et al., 1997) ) may also increase the apparent release of cytochrome c. Therefore, we assayed cell fractions by Mitochondrial membrane potential was assessed visually by confocal microscopy of cells labeled with Mitotracker and antibodies to Hsp-60. In each of the conditions cells were counted from eight ®elds of view accumulated from at least two separate coverslips. The fraction of cells with reduced mitochondrial membrane potential is expressed as a percentage, n is the total number of cells counted Figure 5 Bcl-cb5 inhibits PARP cleavage during apoptosis induced by ceramide or serum starvation/myc (starvation/myc), but not etoposide. Whole cell extracts were prepared from Neo or Bcl-cb5 cells (as indicated to the right of the panels) growing in regular medium (0 h), or exposed to 50 mM ceramide, serum starvation/myc (starvation/myc), or 40 mM etoposide for the number of hours indicated. The migration positions of PARP and its major cleavage product (DPARP) are indicated to the left and the cell line (Neo or Bcl-cb5 expressing) is indicated to the right of the panels immunoblotting with anity puri®ed antibodies to cytochrome c. The sub-cellular fractions were also probed with antibodies to Hsp60 as a mitochondrial marker. Unlike the commonly used marker for mitochondria (the integral membrane protein CoxIV) Hsp60 is a soluble protein located in the mitochondrial matrix therefore, its distribution is also an indicator of the integrity of the inner mitochondrial membrane. In order to break cells without exposing them to hypotonic solutions (known to compromise the outer mitochondrial membrane) we used low pressure nitrogen cavitation. The use of nitrogen cavitation for cell fractionation oers substantial bene®ts as cells are broken in iso-osmotic buer and cavitation results in decreased rupture of outer mitochondrial membranes as compared to mechanical homogenization (Adachi et al., 1998) . Furthermore, cell lysis is more ecient with this technique than with Dounce homogenization in iso-osmotic solutions. Mitochondria isolated from normal cells ruptured by nitrogen cavitation can be pelleted at lower g forces (1000 g, P 1 ) than mitochondria isolated by conventional means (typically 10 ± 15 000 g depending on cell type or tissue source). This result indicates that mitochondria, which are large elongated structures in these cells, are relatively intact when recovered compared to other homogenization protocols (Adachi et al., 1998) . Therefore, after removal of nuclei and cell debris from whole cell lysates by centrifugation at *480 g for 2 min, the distribution of cytochrome c was examined by subjecting 100 microliter aliquots of lysate to centrifugation at 1000 g for 25 min. Centrifugation over a short distance at low g force permitted quantitative recovery of mitochondria (as judged by blotting for Hsp60). Immunoblot analysis demonstrated that on average 95% of the cytochrome c and 96% of the Hsp-60 in untreated (vectortransfected, Bcl-cb5 transfected and Bcl-2 transfected) cells pelleted at 1000 g after homogenization by nitrogen cavitation (Figure 6a ). The variation in total protein recovered in the fractions was approximately 20% for cytochrome c and 15% for Hsp-60 (data not shown). In contrast other attempts to assay cytochrome c release in Rat-1 cells reported signi®cant amounts of cytochrome c in the cytosol of untreated cells (Juin et al., 1999) . We interpret our results as indicating that the mitochondria in Rat-1 cells remain largely intact during processing by low pressure nitrogen cavitation although cell breakage was very ecient as assessed by direct visualization and by immunoblotting for a cytosolic protein (data not shown). We have previously reported that exposure of Rat-1 cells to 40 micromolar etoposide for 18 h is associated with extensive apoptosis, loss of Dc m in more than 50% of cells, and loss of ability to exclude propidium iodide in 30% of cells (Lee et al., 1999) . In this situation Bcl-2, but not Bcl-cb5, prevented both loss of Dc m and cleavage of poly-ADP ribose polymerase (PARP), a substrate for caspase-3 ( Figure 5 , and Lee et al., 1999) . Unlike Bcl-cb5, which is located exclusively on the cytoplasmic face of the endoplasmic reticulum (Zhu et al., 1996) , Bcl-2 is located on both the outer mitochondrial membrane and the cytoplasmic face of the ER (Janiak et al., 1994) . Therefore, our results indicate that Bcl-2 localized to the mitochondrial membrane prevented apoptosis due to etoposide. To determine when cytochrome c is released during apoptosis via a mechanism that cannot be blocked by Bcl-cb5, we assessed the sub-cellular distribution of cytochrome c by confocal microscopy ( Figure 4 ) and by immunoblotting of cell fractions prepared from etoposide treated cells (Figure 6a ).
When we examined the fractionation of cytochrome c in cells treated with etoposide the majority of cytochrome c (88%) was found in the 1000 g supernatant. A small amount of Hsp-60 was also found in the 1000 g supernatant fraction but most of it (87%) was found in the 1000 g pellet, con®rming that after exposure to etoposide, mitochondrial matrix proteins remain associated with very large structures. This result also demonstrates that the cytochrome c recovered in the 1000 g supernatant fraction is not due to fragmentation of the mitochondria.
Bcl-cb5 does not prevent apoptosis due to etoposide, therefore, it was not surprising that Bcl-cb5 does not prevent etoposide induced release of cytochrome c into the 1000 g supernatant (Figure 6a ) or the cleavage of PARP that re¯ects the activation of caspases by cytochrome c (Figure 5 ). In etoposide treated cells expressing Bcl-cb5, 88% of the cytochrome c was recovered in the 1000 g supernatant. In contrast, less than 3% of the cytochrome c was found in the 1000 g supernatant in similarly treated Bcl-2 expressing cells. Thus, in etoposide treated cells, release of cytochrome c into the 1000 g supernatant correlates with apoptosis. We assume that the main reason that more cytochrome c release is detected by fractionation than by confocal microscopy is because both adherent and non-adherent cells are analysed by fractionation.
To determine whether or not redistribution of cytochrome c from the 1000 g pellet to the 1000 g supernatant was dependent on activated caspases we treated cells with the broad spectrum caspase inhibitor zVAD-fmk. This inhibitor abolishes many of the features of apoptosis in etoposide treated, vectortransfected, Rat-1/myc cells. However, redistribution of cytochrome c was not blocked by zVAD-fmk, demonstrating that activated caspases are not essential for this process (Figure 6b ). To determine if the inability of Bcl-cb5 to prevent apoptosis in etoposide treated cells was due to selective caspase cleavage or degradation of Bcl-cb5, cell lysates were analysed by immunoblotting. Comparison of untreated controls with lysates from cell exposed to etoposide for 6 h revealed no signi®cant change in the amount or integrity of either Bcl-2 or Bcl-cb5 (Figure 6c) .
In contrast to etoposide treated cells, at early timepoints during apoptosis due to serum starvation/myc or exposure to ceramide both cytochrome c and Hsp-60 were found almost exclusively in the 1000 g pellet (Figure 6c ). Thus early`release' of cytochrome c is not observed when apoptosis is induced by a mechanism that can be blocked by Bcl-cb5.
Bcl-cb5 does not prevent the etoposide induced conformational change in or membrane translocation of Bax
Previous work suggests that the pro-apoptotic family member Bax can induce the release of mitochondrial cytochrome c (Eskes et al., 1998) . Furthermore, during apoptosis, Bax undergoes a conformational change that allows it to integrate into mitochondrial membranes. This change in Bax structure results in the exposure of a normally inaccessible epitope that is recognized by the monoclonal antibody 6A7. To determine if etoposide induced release of cytochome c is associated with these changes in Bax, we examined the subcellular localization and conformation of Bax by cell fractionation and confocal microscopy in Rat-1 cells exposed to etoposide or ceramide for 6 h.
Cells were disrupted by nitrogen cavitation and the lysates subjected to centrifugation to separate cytosolic and membrane bound fractions. To determine if proteins found in the pellet were integrated into any cellular membranes, a 100 000 g pellet was incubated with sodium carbonate (pH 11.5) and then separated into soluble and membrane fractions by centrifugation. Consistent with other published results, in untreated cells Bax was not membrane bound in either Bcl-cb5 or vector transfected control cells (Figure 7 ). Exposure to etoposide does not change the total amount of Bax in cells (Figure 7 ), but rather causes a re-distribution of approximately 25% (average of two independent experiments) of Bax to a membrane bound fraction in both vector and Bcl-cb5 cells (Figure 7) . Relocalization of Bax to membranes is not observed in either vector or Bcl-cb5 cells exposed to ceramide for 6 h ( Figure 7) .
To con®rm that a major site of Bax membrane integration was mitochondria, and to determine whether or not Bax localization in mitochondria was co-incident with cytochrome c release, localization of 6A7 positive Bax was monitored by confocal microscopy. As expected, the Bax conformation speci®c epitope recognized by 6A7 is not exposed in untreated cells (Figure 8a ). However, etoposide treated cells showed staining of mitochondria with 6A7 yet retained Mitotracker stain (Figure 8b ,c, right two panels). Thus Bax localization at mitochondria precedes loss of Dc m .
The fraction of cells staining with 6A7 did not dier between vector and Bcl-cb5 expressing cells at three dierent time points (data not shown). Moreover, those cells that stained for 6A7 had lost the mitochondrial staining pattern for cytochrome c. Conversely, cells that retained cytochrome c within mitochondria did not stain with 6A7 above background (Figure 8b,c) . This result is congruent with biochemical studies suggesting that translocation of Bax to mitochondria is sucient to provoke cytochrome c release in vitro (Eskes et al., 1998) . Unlike Bcl-cb5, expression of Bcl-2 in these cells was sucient to block the conformation change in Bax that exposes the epitope recognized by 6A7 (data not shown). Taken together, these results suggest that Bcl-2 must be localized to mitochondria to prevent the etoposide induced conformational change in Bax and release of cytochrome c. In contrast to cells treated with etoposide, cells exposed to ceramide retained cytochrome c (Figure 8d ,e, left two panels) and did not stain with 6A7 even in those cells in which loss of Dc m abolished Mitotracker staining (Figure 8d ,e, right two panels).
Discussion
Examination of the temporal ordering of loss of Dc m and release of cytochrome c in response to dierent apoptotic stimuli revealed two spatially distinct pathways of apoptosis in Rat-1 ®broblasts. In the pathway in which cytochrome c release precedes loss of Dc m (e.g. due to etoposide), apoptosis is characterized by an induced structural change in Bax and relocalization of Bax to mitochondrial membranes. Both of these changes can be blocked by Bcl-2 molecules located at the mitochondria. In contrast, when loss of Dc m (measured by cyto¯uorometry using potential sensitive dye DIOC 6 (3) (Figures 1 and 2) or DilCl(5) (Figures 1,  2 and 5 in Lee et al., 1999) or by confocal microscopy using Mitotracker (Figure 4) precedes release of cytochrome c, there is no change in the conformation of Bax, nor is it relocated to mitochondria (Figures 7  and 8d,e) . Nevertheless, this form of cell death is apoptosis, as measured by changes in nuclear morphology (Zhu et al., 1996) , exposure of PS on the outer lea¯et of the plasma membrane (Figure 2b ), fragmentation of nuclear DNA (Figure 2c) , and cleavage of PARP ( Figure 5 ). This form of apoptosis was inhibited by an isoform of Bcl-2 located exclusively at the endoplasmic reticulum (Bcl-cb5). Thus, the two pathways are spatially distinct in Rat-1 cells.
To determine how Bcl-cb5 selectively blocks apoptosis due to serum starvation/myc or ceramide but not apoptosis induced by etoposide, we examined several of the known steps in apoptosis. When we examined serum starvation/myc induced apoptosis by cyto¯uoro-metry in Rat-1 cells, we observed the well characterized sequences of dysfunction reported in other cell types: abolition of the Dc m with concomitant generation of reactive oxygen species, and the activation of eector mechanisms of apoptosis involving changes in the plasma membrane and DNA fragmentation (Figure 1) . Thus it appears that similar to the eects of Bcl-cb5 on ceramide induced apoptosis (Figure 4 ), Bcl-cb5 inhibits serum starvation/myc induced apoptosis in part by preventing the loss of Dc m (Figure 1 and Table 1 ). Previously serum starvation/myc was shown to lead to cytochrome c release in Rat-1 cells and to be required for the late stage events (morphology changes) in apoptosis (Juin et al., 1999) . While we also observed cytochrome c release after serum starvation/myc it was clearly preceded by loss in Dc m . Previous studies have not examined the temporal order of these two events in Rat-1 cells. However, the confocal micrographs of the distribution of cytochrome c after serum starvation/ myc (Juin et al., 1999) are entirely congruent with our observations. Bcl-2 can prevent the loss of Dc m , in isolated intact mitochondria and in an in vitro system with a reconstituted permeability transition pore complex, and inhibits the cell death and decreased Dc m in cells derived from Apaf-1 knock-out mice Marzo et al., 1998; Haraguchi et al., 2000) . Our current results are therefore surprising in that they demonstrate that in living cells Bcl-2 does not have to be localized to the mitochondria to prevent loss of Dc m , and suggest that Bcl-2 can prevent the loss of Dc m by at least two mechanisms: one involving direct intervention in organelle function (Shimizu et al., 1999) , and another which must be indirect to prevent mitochondrial dysfunction from a distance.
How can Bcl-cb5 prevent the loss of Dc m when it is localized to the ER? The loss of Dc m is a consequence of many dierent types of apoptotic stimuli, which may be either caspase dependent or independent. It is therefore plausible that Bcl-2 at the ER, a site distant from the mitochondria, may prevent loss of Dc m by either inhibiting cytosolic caspase activation, inhibiting an ER-localized caspase (Nakagawa et al., 2000) , or protecting a critical caspase substrate that is located at the ER (Ng et al., 1997) . However, our results argue Figure 7 Etoposide, but not ceramide induces Bax membrane binding. Whole cell extracts (W) were prepared by low pressure nitrogen cavitation and then 100 microliters was separated into supernatant (S 100 ) and pellet (P 100 ) fractions by centrifugation at 100 000 g for 1 h. The pellet fraction was resuspended and then incubated in 0.1 M sodium carbonate, pH 11.5 for 30 min at 48C. Membrane bound proteins (P c ) were separated from peripheral proteins (S c ) by centrifugation at 100 000 g for 30 min. Ten micrograms of whole cell lysate and equivalent cell volumes of the supernatant and pellet were immunoblotted with 1D1 anti-Bax antibody. The migration position of Bax is indicated to the left of the panels. Vector transfected Rat-1 cells (Neo) or cells expressing Bcl-cb5 (Bcl-cb5) were untreated or exposed to either 40 mM etoposide or 50 mM ceramide for 6 h against these models as loss of Dc m induced by staurosporine or ceramide was not prevented by the general caspase inhibitor zVAD-fmk (Figure 2 ) yet was inhibited by Bcl-cb5. While ceramide induced loss of Dc m precedes cytochrome c release by several hours our results do not establish a direct causal relationship between these two events.
Bcl-2 has been reported to have other membrane sequestering activities that might be independent of a speci®c membrane site. Bcl-2 and other anti-apoptotic family members such as Bcl-XL have been reported to bind directly to pro-apoptotic family members such as Bax, Bik and Bad (Sedlak et al., 1995; Boyd et al., 1995; Zha et al., 1996) . Thus Bcl-cb5 might prevent apoptosis by sequestering Bax away from mitochondria. However, if this were the case Bax bound to Bclcb5 would have been recovered in the supernatant from the carbonate extraction because pelleted membranes containing Bcl-cb5 were used for this analysis. The membranes were pelleted at 100 000 g in this experiment to ensure that if Bax was localized at any cellular membrane it would be detected. Moreover, if rather than binding to Bcl-cb5, Bax inserts into membrane bilayer because of an interaction with Bcl-cb5, then it would be recovered in the carbonate pellet. As we did not observe Bax in either fraction when Rat 1 cells were treated with ceramide, yet Bax translocation was readily detected in response to etoposide treatment (Figure 7) , we conclude that Bcl-cb5 does not prevent apoptosis by sequestering Bax. Finally, the amino terminal domain of Bcl-2 binds to calcineurin in vivo and in vitro (Shibasaki et al., 1997) , and thereby inhibits its enzymatic activity. While we have not directly addressed the issue of the binding of Bcl-cb5 to calcineurin, our recent results indicate that this interaction may not be relevant in the context of serum starvation/myc induced apoptosis, as there is no detectable increase in cytosolic calcium in these cells as would be necessary for calcineurin activation (Lee et al., 1999) .
Thus, although the apoptosis pathways induced by ceramide and etoposide eventually converge, inhibition of an early step in the ceramide induced pathway by Bcl-cb5 reveals that ceramide induces an apoptosis pathway spatially distinct from Bax mediated apoptosis and for which the early steps are at present largely unknown.
Etoposide perturbs mitochondrial structure
To determine whether Bcl-cb5 prevents cytochrome c release we developed a technique to prepare subcellular fractions that largely preserves the integrity of entire mitochondria, as evidenced by the ecient pelleting of Hsp60 but not cytoplasmic markers at 10006g. Comparison of the results obtained by sub-cellular fractionation and confocal microscopy in Rat-1 cells suggests that the release of cytochrome c from the intermembrane space is an early event in etoposide induced apoptosis. This result is not unique to etoposide early cytochrome c release was also observed when cells were treated with Taxol (Soucie et al., submitted) When cytochrome c is found in the supernatant from the low g force centrifugation, the bulk of the matrix protein Hsp-60 is associated with the low g force pellet. It is possible that the small amount of Hsp-60 found in the low g force supernatant (Figure 6a ) is the same fraction previously reported to contribute to activation of caspase 3 and to be released from the intermembrane space of mitochondria along with cytochrome c during apoptosis (Samadi et al., 1999; Xanthoudakis et al., 1999) . Alternatively, it may represent release of Hsp-60 from the relatively small fraction of mitochondria in which the integrity of the inner membrane was compromised during homogenization and fractionation.
Our data do not permit an unambiguous determination of cause and eect, however in etoposide treated cells the change in Bax conformation and membrane binding associated with the early redistribution of cytochrome c occurs prior to loss in Dc m (Figures 3, 4, 6, 7 and 8) . This result suggests that activation of Bax is a critical event regulating etoposide induced apoptosis. As Bcl-2, but not Bcl-cb5, prevented these changes, it appears that Bcl-2 must be targeted to mitochondria to prevent the change in Bax conformation that initiates the rest of this pathway of apoptosis. Bcl-cb5 may be ineective at inhibiting etoposide induced apoptosis because when located at the ER, it is unable to prevent translocation of Bax to mitochondria (Figure 7 ) or the change in Bax conformation that results in 6A7 positivity ( Figure  8 ). Both Bcl-cb5 and Bcl-2 bind the detergent induced 6A7 positive conformer of Bax (Zhu et al., 1996) . This result indicates that substitution of the carboxyl terminus of Bcl-2 does not alter the structure of the protein such that it is no longer able to bind to Bax. Instead, we do not detect relocalization of Bax to endoplasmic reticulum membranes biochemically (Figure 7) nor do we detect the 6A7 positive conformer of Bax at endoplasmic reticulum (Figure 8 and data not shown). Therefore, it appears that Bcl-cb5 is unable to prevent activation and translocation of Bax because when located at the ER it no longer comes into contact with Bax ( Figure 9 ). We speculate that Bcl-cb5 functions by blocking an as yet unknown, caspase independent signal that eminates from ER and triggers loss of Dc m at mitochondria (Figure 9 ). One hypothesis to account for cytochrome c release in the absence of a decrease in Dc m that is compatible with our data is formation or opening of an outer membrane channel by Bax (Figure 9 and Eskes et al., 1999) . Bcl-2 located at the mitochondria prevents this mode of activating apoptosis (Figure 9 ). Because the decrease in Dc m occurs relatively late (16 ± 18 h (Lee et al., 1999) , and data not shown) compared to cytochrome c release (6 h, Figures 3, 4 and 6) our results indicate that for etoposide induced apoptosis, loss of Dc m is a late ampli®cation event.
Interestingly, redistribution of cytochrome c is a later event than loss of Dc m in those forms of apoptosis for which Bcl-cb5 was an eective inhibitor. However, at time points where there was substantial loss of Dc m , other features of apoptosis such as externalization of PS, DNA fragmentation and cleavage of PARP (Figures 1, 2 and 5) are also observed. Therefore, in apoptosis induced by ceramide, it appears that cytochrome c redistribution acts as a late ampli®er. Our results indicate, but do not prove, that loss of Dc m is critical for commitment to the execution phase of apoptosis in ceramide treated cells.
Taken together, our ®ndings suggest that the debate about the relative importance of mitochondrial transmembrane potential versus cytochrome c release based on data from in vitro model systems can be reconciled by noting that multiple, spatially distinct apoptosis pathways exist in the same cell. These pathways are dierentially sensitive to inhibition by Bcl-cb5 and can be identi®ed by which of the two manifestations of mitochondrial dysfunction occurs ®rst: release of cytochrome c or loss of Dc m .
Materials and methods
Preparation of cellular extracts by nitrogen cavitation
Four 100 mm Petri dishes of cultured cells were harvested in their respective medium using a rubber policeman. The cells were then pelleted by centrifugation in a clinical centrifuge for 3 min at 48C. The cell pellet was washed twice with cell buer (250 mM Sucrose, 20 mM HEPES pH 7.5, 2 mM MgCl 2 , 1 mM NaEDTA, 1 mM PMSF, 1 mM DTT and a cocktail of protease inhibitors). The ®nal pellet was resuspended in an equal volume of cell buer. This suspension was held at 150 p.s.i. for 15 min on ice in a 45 ml Nitrogen Bomb (Parr Instruments) and cells were disrupted by releasing the pressure. The nuclei and cell debris in the expelled lysate were removed by centrifugation at *480 g for 2 min at 48C in a microcentrifuge (Eppendorf). The resulting supernatant, termed the whole cell lysate (WCL), was then split into aliquots of 100 microliters and cytosolic (S 1 ) and pellet (P 1 ) fractions were isolated by centrifugation at 1000 g for 25 min in a Beckman TLA100 rotor. Due to the small volume used in our dierential centrifugation, the distance required to pellet intact mitochondria is small and therefore, in lysates of untreated cells sedimentation of cytochrome c and Hsp-60 in the P 1 fraction is very ecient. Alternatively, for the analysis of Bax localization, the WCL was subjected to centrifugation at 100 000 g for 1 h to generate supernatant (S 100 ) and pellet (P 100 ). Carbonate extraction of membrane fractions was performed as previously described (Janiak et al., 1994) . The fractions were then snap frozen in liquid nitrogen and stored at 7808C. Protein in samples was quanti®ed using a standard Bradford assay (Bio-Rad).
Immunoblotting
Antibodies to Hsp-60 and the 1D1 monoclonal antibody directed against Bax were generous gifts of Dr R Gupta, McMaster University and Dr R Youle, NIH. Sheep antiserum and anity puri®ed antibodies to cytochrome c were obtained from Exalpha Biologicals, Roxbury, MA, USA. The antibody to poly-ADP ribose polymerase (PARP) was purchased from Biomol and used according to the manufacturer's instructions. Rabbit antiserum to Bcl-2 has been described (Zhu et al., 1996) . Protein samples were separated on a 10% polyacrylamide tricene gel, followed by transfer to a PVDF membrane for PARP immunostaining, or to nitrocellulose membrane for other antibodies. The membranes were blocked and then incubated with either anity puri®ed anti-cytochrome c (dilution 1 : 5000), antiHsp60 (dilution 1 : 10 000), anti-PARP (1 : 10 000), anti-Bcl-2 (1 : 10 000) or 1D1 anti-bax (dilution 1 : 5000) antibodies and developed after incubation with peroxidase-conjugated donkey anti-sheep or donkey anti-mouse antibodies (Jackson Laboratories) using an enhanced chemiluminescent detection system (NEN-Life Science). Band intensities were quanti®ed using a densitometer and the data was analysed using ImageQuant software. The variation in recovery from subcellular fractionation was calculated by measuring the total protein recovered from all fractions from duplicate samples processed in parallel for six separate experiments.
Cell death assays
Rat-1/myc cells were grown to *75% con¯uence in a 100 mm Petri dish. After washing twice with PBS, the media was replaced with medium containing either 40 mM Etoposide (for 5 h), 50 mM C2-Ceramide (for 6 h) or 0.1% foetal bovine serum+2 mM estradiol (for 24 h). Cytochrome c release was monitored either by sub-cellular fractionation or immunouorescence microscopy (dilution of anity puri®ed antibodies was 1 : 750). Change in the conformation of Bax was assessed by microscopy using the conformation speci®c antibody 6A7 (dilution 1 : 100). To monitor mitochondrial transmembrane potential by direct visualization, cells were grown on coverslips under the experimental conditions described above. At the end of the exposure to the apoptotic stimulus, Mitotracker dye (Molecular Probes) was added to a concentration of 150 nM. After incubation for 15 min in the dark, the cells were incubated in culture medium at 378C for 15 min and then washed with PBS, ®xed with 4% paraformaldehyde, and with the exception of 6A7 staining, permeabilized and processed conventionally for immunouorescence. For 6A7 immunolocalization cells were permeabilized using CHAPS (0.2%) in PBS. Mitochondrial transmembrane potential was monitored by direct visualization of the accumulation of the dye by comparison with the distribution of the mitochondrial matrix protein Hsp-60 (dilution 1 : 50). Exposure of Mitotracker-treated cells to the protonophore carbamoyl cyanide m-clorophenylhydrazone (m-CICCP) for 15 min resulted in no detectable mitochondrial¯uorescent signal compared to untreated cells, indicating that Mitotracker alone did not substantially aect mitochondrial membrane potential under these conditions (Scorrano et al., 1999) . Control experiments demonstrated that the decreased intensity of Mitotracker staining in cells undergoing apoptosis was not due to variations in stain delivery as staining did not vary signi®cantly in dierent areas of the coverslips (data not shown) and thus is an accurate indicator of the mitochondrial transmembrane potential in the conditions used here. Cyto¯uorometric analysis of mitochondrial transmembrane potentials with 3,3' dihexyloxacarbocyanine iodide (DiOC 6 (3)) and reactive oxygen species were performed as described . Analysis of externalized phosphatidyl serine (PS) by annexin V labelling and nuclear DNA loss by propidium iodine (PI) staining of cells were as described .
Cell culture
Rat-1/myc ®broblasts constitutively expressing human Bcl-2 and Bcl-cb5 (Zhu et al., 1996) were maintained in phenol red minus, alpha-minimal essential medium supplemented with 10% charcoal-®ltered treated foetal bovine serum.
